| J Paul Okeefe, MD | |
|
2160 S 1st Ave, (1950 S. Harlem Ave., North Riverside, Il. 60546), Maywood, IL 60153 | |
| (708) 354-9250 | |
| (708) 354-8765 |
| Full Name | J Paul Okeefe |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 2160 S 1st Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386621647 | NPI | - | NPPES |
| 36047253 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 36047253 (Illinois) | Primary |
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
An international team of scientists has learnt how to determine the spatial structure of a protein obtained with an X-ray laser using the sulfur atoms it contains. This development is the next stage in the project of a group led by Vadim Cherezov to create an effective method of studying receptor proteins.
Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).
Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal Aerosol was similar to placebo.
Oral administration of a cocktail of three viruses, all of which specifically kill cholera bacteria, prevents infection and cholera-like symptoms in animal model experiments, report scientists from Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts in Nature Communications on Feb. 1.
Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| J Paul Okeefe, MD 2160 S 1st Ave, (1950 S. Harlem Ave., North Riverside, Il. 60546), Maywood, IL 60153 Ph: (708) 354-9250 | J Paul Okeefe, MD 2160 S 1st Ave, (1950 S. Harlem Ave., North Riverside, Il. 60546), Maywood, IL 60153 Ph: (708) 354-9250 |
News Archive
An international team of scientists has learnt how to determine the spatial structure of a protein obtained with an X-ray laser using the sulfur atoms it contains. This development is the next stage in the project of a group led by Vadim Cherezov to create an effective method of studying receptor proteins.
Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).
Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal Aerosol was similar to placebo.
Oral administration of a cocktail of three viruses, all of which specifically kill cholera bacteria, prevents infection and cholera-like symptoms in animal model experiments, report scientists from Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts in Nature Communications on Feb. 1.
Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."
› Verified 7 days ago
Dr. Cathryn T Sawalski, DO, MBA Infectious Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Suhana Elamsenthil, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Holly Kramer, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-9033 | |
Dr. Stephanie Bochen Tsai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Nicholas Poellinger, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Sofia Ahmed, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8757 | |
Shelly Lo, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Luh - North Ent., Rm. 7604, Maywood, IL 60153 Phone: 708-216-3304 Fax: 708-216-1259 |